136.07, 134.79, 132.58, 131.61, 131.52, 128.66, 127.85, 127.73, 127.72,
127.54, 126.48, 126.37, 126.31, 126.20, 126.06, 125.71, 122.89, 121.76,
116.59, 115.62. HRMS (MALDI-TOF, m/z): [M+] calcd for C36H27N,
473.2143; found 473.1956.
In Vitro Cell Tracing: MCF-7 breast cancer cells were cultured in 6-well
plates (Costar, IL, USA) to achieve 80% confluence. After medium
removal and washing with 1× PBS buffer, 2 nM Tat-AIE dots or Qtracker
585 in DMEM were then added to the wells. After overnight incubation
at 37 °C, the cells were washed twice with 1× PBS buffer and detached
by 1× tripsin and resuspended in culture medium. Upon dilution, the
cells were subcultured in 6-well plates for 1 to 10 day regeneration,
respectively. After designated time points, the cells were washed twice
with 1× PBS buffer and then trypsinized to suspend in 1× PBS buffer. The
fluorescence intensities of cells were then analyzed by flow cytometry
measurements using Cyan-LX (DakoCytomation) and the histogram of
each sample was obtained by counting 10 000 events (λex = 488 nm,
575/25 nm bandpass filter). For confocal image studies, the cells were
first labeled by 2 nM Tat-AIE dots or Qtracker 585. The labeled cells were
then washed twice with 1× PBS buffer and trypsinized to suspend in
culture medium. The cells were then diluted and subcultured in 6-well
plates containing cell culture coverslips for designated passages. Upon
reaching designated time points, the cells were washed twice with 1×
PBS buffer and then fixed by 75% ethanol for 20 min. The coverslips
were sealed with mounting medium and used for confocal imaging.
Preparation of TNB: The compound was prepared from compound
5 (223 mg, 0.5 mmol), N-(4-(1,2,2-triphenylvinyl)phenyl)naphthalen-1-
amine (10b) (710 mg, 1.5 mmol), Cs2CO3 (1.14 g, 3.5 mmol), Pd(OAc)2
(11.2 mg, 0.05 mmol), and P(t-Bu)3 (30.3 mg, 0.15 mmol), following
the same procedure described above, affording orange red solid in 78%
yield (480 mg). 1H NMR (300 MHz, CDCl3), δ (TMS, ppm): 7.92–7.87 (t,
4H), 7.77 (t, J = 8.4 Hz, 6H), 7.64 (s, 2H), 7.46 (t, J = 8.0 Hz, 4H), 7.41–
7.35 (m, 4H), 7.14–6.99 (m, 34H), 6.86 (s, 8H). 13C NMR (75 MHz,
CDCl3), δ (TMS, ppm):154.28, 148.48, 146.22, 144.13, 143.96, 143.76,
143.13, 140.81, 140.60, 137.83, 135.43, 132.32, 132.16, 131.50, 131.34,
130.27, 129.87, 128.55, 127.76, 127.73, 127.51, 127.38, 126.84, 126.53,
126.47, 126.41, 126.29, 124.44, 121.67, 121.11. HRMS (MALDI-TOF,
m/z): [M+] calcd for C90H62N4S, 1230.4695; found, 1230.5199). Anal.
calcd for C90H62N4S: C, 87.77; H, 5.07; N, 4.55; S, 2.60. found: C, 87.91;
H, 5.15; N, 4.62.
Synthesis of Tat Peptide-Functionalized AIE Dots: Two AIE
chromophores were used in synthesis of Tat peptide-functionalized AIE
dots. TTB (1 mg), DSPE-PEG2000 (1 mg) and DSPE-PEG2000-Mal (1 mg)
were dissolved in 1 mL of THF solution, followed by mixing with 9 mL of
water. The mixture was then sonicated for 60 seconds using a microtip
probe sonicator at 15 W output (XL2000, Misonix Incorporated, NY).
After filtration using a 0.2 μm syringe driven filter, the suspension was
stirred vigorously at room temperature overnight to yield TTB dots in
water (8 mL). The AIE dot suspension (2 mL) was further mixed with
the modified HIV1-Tat peptide (5 × 10−5 M). After reaction overnight at
room temperature, the solution was dialysed against MilliQ water for
2 days to eliminate the excess peptides. The Tat-TTB dots were collected
for further use. TNB was also used to fabricate Tat-TNB dots following
the same experimental procedures.
Cell Culture: MCF-7 breast cancer cells were cultured in DMEM
containing 10% fetal bovine serum and 1% penicillin streptomycin
at 37 °C in a humidified environment containing 5% CO2. Before
experiment, the cells were pre-cultured until confluence was reached.
In Vitro Cell Imaging: MCF-7 breast cancer cells were cultured in
8-well confocal chambers (Costar, IL, USA) to achieve 80% confluence.
The medium was then removed and cell monolayer was washed twice
with 1× PBS buffer. Tat-TTB dots or Tat-TNB dots in DMEM (2 nM) were
then added to the sample wells. After 6 h incubation at 37 °C, the cells
were washed twice with 1× PBS buffer and freshly prepared Hoechst
34580 solution in DMEM (1 μg mL−1) was added into the wells for
further 30 min incubation. The cells were then washed twice with 1× PBS
buffer. After addition of fresh DMEM, the cells were immediately imaged
by Leica TCS SP 5X. The laser at 405 nm (1 mW) was used to obtain
the one-photon excited fluorescence images with 440–480 nm and
600–800 nm bandpass filters for simultaneous collection of fluorescence
from Hoechst 34580 and Tat-AIE dots, respectively.
Cytotoxicity of AIE Dots and Tat-AIE Dots: The metabolic
viability of MCF-7 breast cancer cells were evaluated using
methylthiazolyldiphenyltetrazolium bromide (MTT) assays. MCF-7
breast cancer cells were seeded in 96-well plates (Costar, IL, USA) at an
intensity of 6 × 104 cells mL−1, respectively. After 24 h incubation, the
old medium was replaced by Tat-AIE dot suspension at concentrations
of 1, 2, and 4 nM, and the cells were then incubated for 24 h and 48 h,
respectively. The wells were then washed twice with 1× PBS buffer and
100 μL of freshly prepared MTT (0.5 mg mL−1) solution in culture
medium was added into each well. The MTT medium solution was
carefully removed after 3 h incubation. Filtered DMSO (100 μL) was
then added into each well and the plate was gently shaken for 10 min
to dissolve all the precipitates formed. The absorbance of MTT at
570 nm was monitored by the microplate reader (Genios Tecan). Cell
metabolic viability was expressed by the ratio of the absorbance of the
cells incubated with Tat-AIE dot suspension to that of the cells incubated
with culture medium only.
Supporting Information
Supporting Information is available from the Wiley Online Library or
from the author.
Acknowledgment
W.Q. and K.L. contributed equally to this work. This work was partially
supported by the National Basic Research Program of China (973
Program, 2013CB834701), the RPC and SRFI Grants of HKUST
(RPC11SC09 and SRFI11SC03PG), the Research Grants Council of Hong
Kong (HKUST2/CRF/10 and N_HKUST620/11), and the University
Grants Committee of Hong Kong (AoE/P-03/08), and Singapore
Institute of Materials Research and Engineering (IMRE/13-8P1104;
IMRE/13-1P0909), and National Research Foundation (R279-000-390-
281). The authors thank the support of the Guangdong innovative
Research Team Program (201101C0105067115). The authors also thank
Professor Kam Sing Wong in Department of Physics, HKUST for the
measurement of fluorescence quantum yields of solid powder samples.
Received: June 21, 2013
Revised: July 12, 2013
Published online:
[1] a) B. N. G. Giepmans, S. R. Adams, M. H. Ellisman, R. Y. Tsien, Sci-
ence 2006, 312, 217; b) T. Terai, T. Nagano, Curr. Opin. Chem. Biol.
2008, 12, 515.
[2] a) D. W. Domaille, E. L. Que, C. J. Chang, Nat. Chem. Biol. 2008,
4, 168; b) R. Y. Tsien, Angew. Chem. Int. Edit. 2009, 48, 5612;
c) M. Y. Hu, L. Li, H. Wu, Y. Su, P. Y. Yang, M. Uttamchandani,
Q. H. Xu, S. Q. Yao, J. Am. Chem. Soc. 2011, 133, 12009.
[3] a) S. Wang, T. Hazelrigg, Nature 1994, 369, 400; b) C. J. Daly,
J. C. McGrath, Pharmacol. Ther. 2003, 100, 101.
[4] a) F. Q. Chen, D. Gerion, Nano Lett. 2004, 4, 1827; b) J. K. Jaiswal,
E. R. Goldman, H. Mattoussi, S. M. Simon, Nat. Methods 2004, 1,
73; c) L. S. Shah, P. A. Clark, E. K. Moioli, M. A. Stroscio, J. J. Mao,
Nano Lett. 2007, 7, 3071.
[5] Y. G. Meng, J. Liang, W. L. Wong, V. Chisholm, Gene 2000, 242, 201.
[6] E. Dellambra, G. Pellegrini, L. Guerra, G. Ferrari, G. Zambruno,
F. Mavilio, M. De Luca, Hum. Gene Ther. 2000, 11, 2283.
[7] a) X. H. Gao, Y. Y. Cui, R. M. Levenson, L. W. K. Chung, S. M. Nie,
Nat. Biotechnol. 2004, 22, 969; b) X. Michalet, F. F. Pinaud,
©
8
wileyonlinelibrary.com
2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Funct. Mater. 2013,
DOI: 10.1002/adfm.201302114